Is Pharmacyte Biotech Inc (PMCB) Stock a Smart Investment Tuesday?

Pharmacyte Biotech Inc (PMCB) stock is down -27.08% over the last 12 months. InvestorsObserver’s proprietary ranking system, gives PMCB stock a score of 16 out of a possible 100.

That rank is chiefly influenced by a long-term technical score of 21. PMCB's rank also includes a short-term technical score of 26.

PMCB has an Overall Score of 16. Find out what this means to you and get the rest of the rankings on PMCB!

See Full PMCB Report

What's Happening with PMCB Stock Today

Pharmacyte Biotech Inc (PMCB) stock is higher by 4.48% while the S&P 500 is up 0.19% as of 12:33 PM on Tuesday, Oct 24. PMCB is up $0.09 from the previous closing price of $2.01 on volume of 10,954 shares. Over the past year the S&P 500 has risen 11.27% while PMCB is down -27.08%. PMCB lost -$0.54 per share in the over the last 12 months. Click Here to get the full Stock Report for Pharmacyte Biotech Inc stock.